Braicu Vlad, Fulger Lazar, Nelluri Aditya, Maganti Ram Kiran, Shetty Uday Shree Akkala, Verdes Gabriel, Brebu Dan, Dumitru Catalin, Toma Ana-Olivia, Rosca Ovidiu, Duta Ciprian
Doctoral School, "Victor Babes" University of Medicine and Pharmacy Timisoara, Eftimie Murgu Square 2, 300041 Timisoara, Romania.
Department of General Surgery, "Victor Babes" University of Medicine and Pharmacy Timisoara, Eftimie Murgu Square 2, 300041 Timisoara, Romania.
Diseases. 2023 Dec 11;11(4):181. doi: 10.3390/diseases11040181.
The global pandemic period from 2020 to 2022 caused important alterations in oncology care. This study aimed to describe the trends and variations in patient characteristics, comorbidities, and treatment approaches during this time in Romania. We conducted a retrospective database search to identify patients with rectal cancer who underwent surgical intervention between 2020 and 2022 and the year 2019, which served as a pre-pandemic period control. This study included 164 patients, with a yearly increase of approximately 10% in surgical interventions noted from 2020 (1709 interventions) to 2022 (2118 interventions), but an overall 34.4% decrease compared with the pre-pandemic period. Notable shifts were observed in the type of surgeries performed, with laparoscopic procedures doubling from 2020 (25%) to 2022 (47.5%), confirming the decrease in emergency presentations during the last year of the COVID-19 pandemic and a recovery to normality with planned, elective interventions. Elective interventions increased significantly in 2022 (79.7%) compared with the previous years ( = 0.043), with a concurrent rise in neoadjuvant therapy uptake in 2022 (35.6%). However, significant alterations in the TNM staging, from 12.5% stage IV cases in 2020 to 25.4% in 2022 ( = 0.039), indicated an increased diagnosis of advanced stages of rectal cancer as the years progressed. There was a significant difference in albumin levels over the years ( = 0.019) and in the American Society of Anesthesiology (ASA) scores (from 6.2% ASA stage IV in 2020 to 16.9% in 2022), denoting an increase in case complexity ( = 0.043). This study reveals a trend of increasing surgical interventions and the prevalence of more advanced stages of rectal cancer during the pandemic years. Despite the subtle fluctuations in various patient characteristics and treatment approaches, notable shifts were documented in the severity at diagnosis and surgery types, pointing toward more advanced disease presentations and changes in surgical strategies over the period studied. Nevertheless, the trends in ICU admission rates and mortality did not alter significantly during the pandemic period.
2020年至2022年的全球大流行时期给肿瘤护理带来了重大改变。本研究旨在描述罗马尼亚在此期间患者特征、合并症及治疗方法的趋势和变化。我们进行了一项回顾性数据库搜索,以确定2020年至2022年以及2019年(作为大流行前时期的对照)期间接受手术干预的直肠癌患者。本研究纳入了164例患者,从2020年(1709例手术)到2022年(2118例手术),手术干预数量每年约增加10%,但与大流行前时期相比总体下降了34.4%。在实施的手术类型上观察到显著变化,腹腔镜手术从2020年的25%增至2022年的47.5%,这证实了在新冠大流行的最后一年急诊病例减少,以及随着计划性择期干预恢复正常。与前几年相比,2022年择期干预显著增加(79.7%)(P = 0.043),同时2022年新辅助治疗的采用率也有所上升(35.6%)。然而,TNM分期有显著变化,从2020年的12.5%为IV期病例到2022年的25.4%(P = 0.039),表明随着时间推移,直肠癌晚期的诊断有所增加。多年来白蛋白水平(P = 0.019)和美国麻醉医师协会(ASA)评分(从2020年的6.2%为ASA IV期到2022年的16.9%)存在显著差异,表明病例复杂性增加(P = 0.043)。本研究揭示了大流行期间手术干预增加以及直肠癌更晚期阶段患病率上升的趋势。尽管患者的各种特征和治疗方法存在细微波动,但在诊断时的严重程度和手术类型方面记录到了显著变化,表明在所研究期间疾病表现更晚期且手术策略发生了变化。然而,大流行期间重症监护病房入住率和死亡率的趋势没有显著改变。